Search Results
Optimizing outcomes in EGFR mutation-positive NSCLC with TKIs
EGFR-Mutant NSCLC: Optimizing Therapy Selection
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive NSCLC
Improving Outcomes in EGFRm NSCLC with TKI Combination Treatment | Dr. Natasha Leighl | CRSF 2023
Strategies to Improve Outcomes with New EGFR Positive TKIs in Advanced NSCLC
Optimizing Therapy at Progression of EGFR-Mutant NSCLC
EGFR TKIs for Upfront Treatment of NSCLC
Optimizing NSCLC treatment with biomarker testing insights
TATTON: Updated results for patients with EGFR-mutant positive NSCLC
Response to systemic anti-cancer therapy in uncommon EGFR mutations
Options for EGFR Mutation-Positive Patients with T790M Mutation-Negative Acquired Resistance
Part 6 - Optimal Management of EGFR Mutation Positive Advanced Lung Cancer - Dr Shyam Aggarwal
